Coronavirus (COVID-19) Vaccine Found 92% Effective in Israel, Outside Clinical Trials
- 3 years ago
Pfizer’s coronavirus vaccine is showing 92 percent effectiveness in Israel, according to the world’s first big controlled investigation on how it works outside of clinical tests.
Only 31 out of 163,000 Israelis vaccinated by Maccabi Healthcare Services were diagnosed with COVID-19 in their first 10 days of full-strength protection, its top vaccine statistics analyst, Anat Ekka Zohar, told The Times of Israel on Thursday.
Maccabi found that an equivalent sample of unvaccinated Israelis was 11 times more likely to be diagnosed with the coronavirus, which allowed it to calculate the effectiveness rate.
Pfizer achieved 95% efficacy in clinical trials, and doctors worldwide are looking to Israel with bated breath to see whether the vaccine comes close to that figure in real-world use.
This article was originally written by Sam Meredith for CNBC on January 20, 2021:
http://bit.ly/3aNYknG
FIND the model and photographer created this video on Pexels:
https://bit.ly/3rC552B
SUBSCRIBE to our channel:
http://bit.ly/3pOwYUZ
Only 31 out of 163,000 Israelis vaccinated by Maccabi Healthcare Services were diagnosed with COVID-19 in their first 10 days of full-strength protection, its top vaccine statistics analyst, Anat Ekka Zohar, told The Times of Israel on Thursday.
Maccabi found that an equivalent sample of unvaccinated Israelis was 11 times more likely to be diagnosed with the coronavirus, which allowed it to calculate the effectiveness rate.
Pfizer achieved 95% efficacy in clinical trials, and doctors worldwide are looking to Israel with bated breath to see whether the vaccine comes close to that figure in real-world use.
This article was originally written by Sam Meredith for CNBC on January 20, 2021:
http://bit.ly/3aNYknG
FIND the model and photographer created this video on Pexels:
https://bit.ly/3rC552B
SUBSCRIBE to our channel:
http://bit.ly/3pOwYUZ